Abeer Mogadem

Mrs. Abeer Mogadem

lecterure of biochemistry, chemistry department, faculty of science, Taibah university
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Abeer MogademAbeer Mogadem
Abeer Mogadem
MAMohamed Ali Almamary
Mohamed Ali Almamary
Naji Arafat MahatNaji Arafat Mahat
Naji Arafat Mahat
Khairunadwa JemonKhairunadwa Jemon
Khairunadwa Jemon
WAWan Azlina Ahmad
Wan Azlina Ahmad
Imran AliImran Ali
Imran Ali
The current research is focused on studying the biological efficacy of flexirubin, a pigment extracted from Chryseobacterium artocarpi CECT 8497.Different methods such as DPPH, H2O2, NO•, O2•−, •OH, lipid peroxidation inhibition by FTC and TBA, ferric reducing and ferrous chelating activity were carried out to evaluate the antioxidant activity of flexirubin. Molecular docking was also carried out, seeking the molecular interactions of flexirubin and a standard antioxidant compound with SOD enzyme to figure out the possible flexirubin activity mechanism. The new findings revealed that the highest level of flexirubin exhibited similar antioxidant activity as that of the standard compound according to the H2O2, •OH, O2•−, FTC and TBA methods. On the other hand, flexirubin at the highest level has shown lower antioxidant activity than the positive control according to the DPPH and NO• and even much lower when measured by the FRAP method. Molecular docking showed that the interaction of flexirubin was in the binding cavity of the SOD enzyme and did not affect its metal-binding site. These results revealed that flexirubin has antioxidant properties and can be a useful therapeutic compound in preventing or treating free radical-related diseases.

28 September 2022 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
TWTet Soon Wong
Tet Soon Wong
FTFatahiya Mohamed Tap
Fatahiya Mohamed Tap
ZHZanariah Hashim
Zanariah Hashim
FMFadzilah Adibah Abdul Majid
Fadzilah Adibah Abdul Majid
NZNor Hafizah Zakaria
Nor Hafizah Zakaria
Abeer MogademAbeer Mogadem
Abeer Mogadem
Common treatments for the management of diabetes have limitations due to side effects, hence the need for continuous research to discover new remedies with better therapeutic efficacy. Previously, we have reported that the combination treatment of gallic acid (20 mg/kg) and andrographolide (10 mg/kg) for 15 days demonstrated synergistic hypoglycemic activity in the streptozotocin (STZ)-induced insulin-deficient diabetes rat model. Here, we attempt to further elucidate the effect of this combination therapy at the biochemical, histological and molecular levels. Our biochemical analyses showed that the combination treatment significantly increased the serum insulin level and decreased the total cholesterol and triglyceride level of the diabetic animals. Histological examinations of H&E stained pancreas, liver, kidney and adipose tissues of combination-treated diabetic animals showed restoration to the normalcy of the tissues. Besides, the combination treatment significantly enhanced the level of glucose transporter-4 (GLUT4) protein expression in the skeletal muscle of treated diabetic animals compared to single compound treated and untreated diabetic animals. The molecular docking analysis on the interaction of gallic acid and/or andrographolide with the adiponectin receptor 1 (AdipoR1), a key component in the regulation of pancreatic insulin secretion, revealed a greater binding affinity of AdipoR1 to both compounds compared to individual compounds. Taken together, these findings suggest the combination of gallic acid and andrographolide as a potent therapy for the management of diabetes mellitus.

3 April 2025 in Ceramics International
Verified
Journal Article
Closed access
Abeer MogademAbeer Mogadem
Abeer Mogadem
Bassma ElwakilBassma Elwakil
Bassma Elwakil
FAFaizah Salah Aljohani
Faizah Salah Aljohani
KPKeshav Raj Paudel
Keshav Raj Paudel
Mostafa El khatibMostafa El khatib
Mostafa El khatib

18 August 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Abeer MogademAbeer Mogadem
Abeer Mogadem
HEHadir El-Kady
Hadir El-Kady
AEAreej Eskandrani
Areej Eskandrani
BABasant A. Abou-Taleb
Basant A. Abou-Taleb
SSSally Salah
Sally Salah
Bassma ElwakilBassma Elwakil
Bassma Elwakil